J. PaulDuicMD

PubMed

• 1 citations
  An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
  Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Bu...> ;CNS Oncology. 2023 Sep 1
• 89 citations
  Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
  , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2020 Feb 7
• 10 citations
  An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
  Charles Cobbs, Edward McClay, J. Paul Duic, L. Burt Nabors, Donna Morgan Murray, Santosh Kesari> ;CNS Oncology. 2019 Mar 1
• In-111 DTPA ommaya cisternography with delayed radiotracer activity demonstrated in the peritoneal cavity.
  Luke R. Scalcione, Douglas S. Katz, Paul J. Duic, Jai Grewal, Elizabeth Yung> ;Clinical Nuclear Medicine. 2009 Dec 1
• 9 citations
  Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (...
  Linda M. Liau, Keyoumars Ashkan, David Tran, Jian Campian, John E. Trusheim, Charles S. Cobbs, Jason Heth, Michael Salacz, Sarah A. Taylor, Stacy D. D’Andre, Fabio M. ...> ;Journal of Translational Medicine. 2018 Jun 29
• 170 citations
  First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
  Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Charles S Cobbs, Jason A Heth, Michael Salacz, Sarah Taylor, Stacy D D'Andre, Fabio M Iw...> ;Journal of Translational Medicine. 2018 May 29
• Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
  Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perr...> ;The Lancet. Oncology. 2017-08-23
• 1 citations
  Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.
  J. Paul Duic, Jai Grewal, Kerry McConie, Harry Staszewski, Jonathan A. Haas, Santosh Kesari> ;Journal of Neuro-Oncology. 2012 Jan 1
• 76 citations
  Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
  Fabio M. Iwamoto, Teri N. Kreisl, Lyndon Kim, J. Paul Duic, John A. Butman, Paul S. Albert, Howard A. Fine> ;Cancer. 2010 Apr 1
• 44 citations
  A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
  Teri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Svetlana Kotliarova, Jennifer Walling, Luna Musib, Donald Thornton, Paul S. Albert, Howard A. Fine> ;Clinical Cancer Research. 2009 May 15
• 1216 citations
  Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
  Teri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Cheryl Royce, Irene Stroud, Nancy Garren, Megan Mackey, John A. Butman, Kevin Camphausen, John W. Park, Paul S. Alb...> ;Journal of Clinical Oncology. 2009 Feb 10
• 54 citations
  A Phase I Trial of Lenalidomide in Patients with Recurrent Primary Central Nervous System Tumors
  Howard A. Fine, Lyndon Kim, Paul S. Albert, J. Paul Duic, Hilary Ma, Wei Zhang, Tanyifor M. Tohnya, William D. Figg, Cheryl Royce> ;Clinical Cancer Research. 2007 Dec 1
• Join now to see all